FDA to Hold First Public Meeting on CBDLast Updated: May 31, 2019. A public meeting on cannabidiol (CBD) products will be held Friday by the U.S. Food and Drug Administration, with the goal of gathering information on products that contain CBD.
FRIDAY, May 31, 2019 (HealthDay News) -- A public meeting on cannabidiol (CBD) products will be held Friday by the U.S. Food and Drug Administration, with the goal of gathering information on products that contain CBD.
CBD products are increasingly popular and include items such as oils, capsules, lotions, and gummies.
The meeting is the first FDA public meeting on CBD and the first step toward regulating it, NBC News reported. The dozens of scheduled speakers at the meeting include doctors, consumers, and cannabis industry members, NBC News reported.
"We are reviewing available databases and medical literature about CBD's safety. Thus far, the data appear insufficient," FDA Principal Deputy Commissioner Amy Abernethy, M.D., recently wrote on Twitter, NBC News reported. "What happens if you eat food with CBD in it, use CBD-infused skin cream, and use other CBD-based products on the same day? What if you use these products daily for a week or a month, or longer?"
|Previous: Impaired Vision Tied to Perceived Discrimination in Older Adults||Next: May 2019 Briefing - Allergy|
Reader comments on this article are listed below. Review our comments policy.